Showing results (1211-1220 of 7,510) with videos related to
Sort By:
Pageof 751
Bioconjugate Chemistry|January 18, 2007
Enzymatic and nonenzymatic synthesis of glutathione conjugates: application to the understanding of a parasite's defense system and alternative to the discovery of potent glutathione S-transferase inhibitorsWei-Jen Lo, Yu-Ching Chiou, Yu-Ting Hsu, et al.Bioconjugate Chemistry|January 18, 2007
Novel bioreducible poly(amido amine)s for highly efficient gene deliveryChao Lin, Zhiyuan Zhong, Martin C Lok, et al.Bioconjugate Chemistry|January 18, 2007
Fluorescent ligands for the hemagglutinin of influenza A: synthesis and ligand binding assaysV Ranjit N Munasinghe, John E T Corrie, Geoff Kelly, et al.Bioconjugate Chemistry|February 24, 2007
Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregationRuben J Boado, Yufeng Zhang, Yun Zhang, et al.Bioconjugate Chemistry|February 24, 2007
Strategies for the labeling of halogen-substituted peroxisome proliferator-activated receptor gamma ligands: potential positron emission tomography and single photon emission computed tomography imaging agentsByung Chul Lee, Kyo Chul Lee, Hsiaoju Lee, et al.Bioconjugate Chemistry|March 8, 2007
Fluorescent nanoparticles for multiplexed bacteria monitoringLin Wang, Wenjun Zhao, Meghan B O'Donoghue, et al.Bioconjugate Chemistry|March 21, 2007
Construction of intramolecular luciferase complementation probe for detecting specific RNATamaki Endoh, Masayasu Mie, Hisakage Funabashi, et al.Bioconjugate Chemistry|March 21, 2007
Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic methodElizabeth Boeggeman, Boopathy Ramakrishnan, Charlton Kilgore, et al.Bioconjugate Chemistry|March 22, 2007
Synthesis and radiolabeling of selective high-affinity ligands designed to target non-Hodgkin's lymphoma and leukemiaSaphon Hok, Arutselvan Natarajan, Rod Balhorn, et al.Bioconjugate Chemistry|March 10, 2007
Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in miceDavid Filpula, Karen Yang, Amartya Basu, et al.Pageof 751